Accès libre

Tuberculosis at the time of Coronavirus disease (COVID-19) lockdown - Back to the days of yore!!!

À propos de cet article

Citez

1. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019—COVID-19. Clinical Microbiology Reviews. 2020;33: e00028-20.10.1128/CMR.00028-20 Search in Google Scholar

2. Gagneux S. Ecology and evolution of Mycobacterium tuberculosis. Nature Reviews Microbiology 2018;16: 202–213.10.1038/nrmicro.2018.8 Search in Google Scholar

3. Prasad R, Singh A, Gupta N. Tuberculosis and COVID-19 in India: Challenges and opportunities. Lung India. 2020;37(4): 292–294.10.4103/lungindia.lungindia_260_20 Search in Google Scholar

4. Stop TB Partnership. The potential impact of the covid-19 response on tuberculosis in high-burden countries: a modelling analysis. Available from: http://www.stoptb.org/assets/documents/news/Modeling%20Report_1%20May%202020_FINAL.pdf [Accessed 6th April 2021]. Search in Google Scholar

5. Hogan AB, Jewell BL, Sherrard-Smith E, Vesga JF, Watson OJ, Whittaker C, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. The Lancet Global Health 2020;8: e1132–e1141.10.1016/S2214-109X(20)30288-6 Search in Google Scholar

6. Dookie N, Padayatchi N, Naidoo K. Tuberculosis elimination in the Era of COVID-19: a moving target. Clinical Infectious Diseases. 2020;ciaa1400. doi: 10.1093/cid/ciaa1400.10.1093/cid/ciaa1400754336432927477 Search in Google Scholar

7. Jain VK, Iyengar KP, Samy DA, Vaishya R. Tuberculosis in the era of COVID-19 in India. Diabetology & Metabolic Syndrome. 2020;14(5): 1439–1443.10.1016/j.dsx.2020.07.034738728732755848 Search in Google Scholar

8. Ronald LA, FitzGerald JM, Benedetti A, Boivin JF, Schwartzman K, Bartlett-Esquilant G, et al. Predictors of hospitalization of tuberculosis patients in Montreal, Canada: a retrospective cohort study. BMC Infectious Diseases. 2016;16(1): 679.10.1186/s12879-016-1997-x511123227846812 Search in Google Scholar

9. Bhargava A, Bhargava M. Tuberculosis deaths are predictable and preventable: comprehensive assessment and clinical care is the key. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases. 2020;19: 1001552.10.1016/j.jctube.2020.100155708261032211519 Search in Google Scholar

10. Government of India. Central Tuberculosis Division. India TB report 2020. Available from: https://tbcindia.gov.in/ [Accessed 7th April 2021]. Search in Google Scholar

11. Taylor Z, Marks SM, Ríos Burrows NM, Weis SE, Stricof RL, Miller B. Causes and costs of hospitalization of tuberculosis patients in the United States. The International Journal of Tuberculosis and Lung Disease. 2000;4(10): 931–939. Search in Google Scholar

12. Aparecida RA, Nemoto MT. Admission for tuberculosis to a university hospital. Pneumologia 2003;29(1): 9–14.10.1590/S0102-35862003000100004 Search in Google Scholar

13. The Global Fund. Global fund survey: majority of HIV, TB and malaria programs face disruptions as a result of COVID-19. 2020. Available from: https://www.theglobalfund.org/en/covid-19/news/2020-06-17-global-fund-survey-majority-of-hiv-tband-malaria-programs-face-disruptions-as-a-result-of-covid-19/ [Accessed 6th April 2020]. Search in Google Scholar

14. Crisan-Dabija R, Grigorescu C, Pavel CA, Artene B, Popa IV, Cernomaz A, et al. Tuberculosis and COVID-19: lessons from the past viral outbreaks and possible future outcomes. Canadian Respiratory Journal. 2020;2020: 1401053.10.1155/2020/1401053747947432934758 Search in Google Scholar

15. Walaza S, Cohen C, Tempia S, Moyes J, Nguweneza A, Madhi SA, et al. Influenza and tuberculosis co-infection: a systematic review. Influenza and Other Respiratory Viruses. 2020;14(1): 77–91.10.1111/irv.12670692805931568678 Search in Google Scholar

16. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020;382: 1708–1720.10.1056/NEJMoa2002032709281932109013 Search in Google Scholar

17. Government of India. Ministry of Health and Family Welfare (MOHFW). eSanjeevani- an Integrated Telemedicine Solution. Available from: https://esanjeevani.in/. Search in Google Scholar

18. Government of India. Ministry of Health and Family Welfare (MOHFW). Accredited SocialHealthActivist(ASHA). Available from: https://nhm.gov.in/index1.php?lang1/41&level1/41&sublinkid1/4150&lid1/4226. [Accessed 7th April 2021]. Search in Google Scholar

19. ICMR approves use of diagnostic machine for drug resistant TB for COVID19. Available from: https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/icmrapproves-useof-diagnostic-machine-used-for-drug-resistant-tb-for-covid19/articleshow/75081319.cms?from1/4mdr. [Accessed 7th April 2021]. Search in Google Scholar

eISSN:
2247-059X
Langue:
Anglais
Périodicité:
Volume Open
Sujets de la revue:
Medicine, Clinical Medicine, other, Internal Medicine, Pneumology